These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32103925)

  • 21. Treatment trends in patients with asthma-COPD overlap syndrome in a COPD cohort: findings from a real-world survey.
    Ding B; Small M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1753-1763. PubMed ID: 28670116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inverse relationship between nonadherence to original GOLD treatment guidelines and exacerbations of COPD.
    Foda HD; Brehm A; Goldsteen K; Edelman NH
    Int J Chron Obstruct Pulmon Dis; 2017; 12():209-214. PubMed ID: 28123293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of compliance with GOLD treatment recommendations on COPD health care resource utilization, cost, and exacerbations among patients with COPD on maintenance therapy.
    Palli SR; Zhou S; Shaikh A; Willey VJ
    J Manag Care Spec Pharm; 2021 May; 27(5):625-637. PubMed ID: 33779246
    [No Abstract]   [Full Text] [Related]  

  • 24. Prescription Status and Clinical Outcomes of Methylxanthines and Leukotriene Receptor Antagonists in Mild-to-Moderate Chronic Obstructive Pulmonary Disease.
    Lee JK; Rhee CK; Kim K; Ra SW; Lee JH; Jung KS; Yoo KH; Kim YI; Kim DK
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2639-2647. PubMed ID: 31819397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids.
    Asche CV; Leader S; Plauschinat C; Raparla S; Yan M; Ye X; Young D
    Int J Chron Obstruct Pulmon Dis; 2012; 7():201-9. PubMed ID: 22500120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COPD patients prescribed inhaled corticosteroid in general practice: Based on disease characteristics according to guidelines?
    Savran O; Godtfredsen N; Sørensen T; Jensen C; Ulrik CS
    Chron Respir Dis; 2019; 16():1479973119867949. PubMed ID: 31431060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of COPD exacerbations in primary care: a clinical cohort study.
    Sundh J; Österlund Efraimsson E; Janson C; Montgomery S; Ställberg B; Lisspers K
    Prim Care Respir J; 2013 Dec; 22(4):393-9. PubMed ID: 24114334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bronchodilators use in patients with COPD.
    Dong YH; Hsu CL; Li YY; Chang CH; Lai MS
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1769-79. PubMed ID: 26366069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of adherence to the GOLD guidelines on symptom prevalence, lung function decline and exacerbation rate in the Swiss COPD cohort.
    Jochmann A; Scherr A; Jochmann DC; Miedinger D; Török SS; Chhajed PN; Tamm M; Leuppi JD
    Swiss Med Wkly; 2012; 142():w13567. PubMed ID: 22481636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stability of the frequent COPD exacerbator in the general population: A Danish nationwide register-based study.
    Reilev M; Lykkegaard J; Halling A; Vestbo J; Søndergaard J; Pottegård A
    NPJ Prim Care Respir Med; 2017 Apr; 27(1):25. PubMed ID: 28416794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How far is real life from COPD therapy guidelines? An Italian observational study.
    Corrado A; Rossi A
    Respir Med; 2012 Jul; 106(7):989-97. PubMed ID: 22483189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Respiratory pharmacotherapy use in patients newly diagnosed with chronic obstructive pulmonary disease in a primary care setting in the UK: a retrospective cohort study.
    Wurst KE; Shukla A; Muellerova H; Davis KJ
    COPD; 2014 Sep; 11(5):521-30. PubMed ID: 24945236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Real life profile of asthma and chronic obstructive pulmonary disease patients in Turkey.
    Mısırlıgil Z; Çımrın A; Günen H; Özlü T; Çilli A; Akyıldız L; Bayram H; Gemicioğlu B; Uzaslan E; Abadoğlu Ö; Suerdem M
    Tuberk Toraks; 2017 Sep; 65(3):169-179. PubMed ID: 29135394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prescription of opioids for breathlessness in end-stage COPD: a national population-based study.
    Ahmadi Z; Bernelid E; Currow DC; Ekström M
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2651-2657. PubMed ID: 27799763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. From Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines to current clinical practice : an overview of the pharmacological therapy of stable chronic obstructive pulmonary disorder.
    Incalzi RA; Corsonello A; Pedone C; Masotti G; Bellia V; Grassi V; Rengo F
    Drugs Aging; 2006; 23(5):411-20. PubMed ID: 16823994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic obstructive pulmonary disease - diagnosis and management of stable disease; a personalized approach to care, using the treatable traits concept based on clinical phenotypes. Position paper of the Czech Pneumological and Phthisiological Society.
    Zatloukal J; Brat K; Neumannova K; Volakova E; Hejduk K; Kocova E; Kudela O; Kopecky M; Plutinsky M; Koblizek V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Dec; 164(4):325-356. PubMed ID: 33325455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution and characteristics of COPD phenotypes - results from the Polish sub-cohort of the POPE study.
    Kania A; Krenke R; Kuziemski K; Czajkowska-Malinowska M; Celejewska-Wójcik N; Kuźnar-Kamińska B; Farnik M; Bokiej J; Miszczuk M; Damps-Konstańska I; Grabicki M; Trzaska-Sobczak M; Sładek K; Batura-Gabryel H; Barczyk A
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1613-1621. PubMed ID: 29844667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emergency department management of acute exacerbations of chronic obstructive pulmonary disease in the elderly: the Multicenter Airway Research Collaboration.
    Cydulka RK; Rowe BH; Clark S; Emerman CL; Camargo CA;
    J Am Geriatr Soc; 2003 Jul; 51(7):908-16. PubMed ID: 12834509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical audit of COPD in outpatient respiratory clinics in Spain: the EPOCONSUL study.
    Calle Rubio M; Alcázar Navarrete B; Soriano JB; Soler-Cataluña JJ; Rodríguez González-Moro JM; Fuentes Ferrer ME; López-Campos JL
    Int J Chron Obstruct Pulmon Dis; 2017; 12():417-426. PubMed ID: 28182155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and distribution of COPD phenotypes in clinical practice according to Spanish COPD Guidelines: the FENEPOC study.
    Calle Rubio M; Casamor R; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2373-2383. PubMed ID: 28848338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.